{
  "image_filename": "table_p6_det_5_006.png",
  "image_path": "Grohskopf_et_al.__2023_/extracted/figures/table_p6_det_5_006.png",
  "image_type": "Table",
  "page_number": 6,
  "block_id": "det_5_006",
  "claim_id": "claim_006",
  "claim": "Flublok is produced using a novel production platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS).",
  "supports_claim": false,
  "explanation": "Table listing contraindications and precautions for influenza vaccines ccIIV4, RIV4, and aIIV4, with bullet points under each vaccine type and footnotes defining abbreviations. The table provides contraindications for RIV4 but does not mention Flublok by name or describe any production platform, insect cells, or baculovirus expression vector system, and thus does not support the claim. Note: No manufacturing or production details are present in the table.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "Table listing contraindications and precautions for influenza vaccines ccIIV4, RIV4, and aIIV4, with bullet points under each vaccine type and footnotes defining abbreviations.",
    "evidence_found": null,
    "reasoning": "The table provides contraindications for RIV4 but does not mention Flublok by name or describe any production platform, insect cells, or baculovirus expression vector system, and thus does not support the claim.",
    "confidence_notes": "No manufacturing or production details are present in the table."
  }
}